Adjuvant RT May Cut Recurrence in Some With Prostate Cancer
Adjuvant radiotherapy after surgery may prolong biochemical recurrence-free survival.
Adjuvant radiotherapy after surgery may prolong biochemical recurrence-free survival.
Higher recurrence risk linked to older age, more advanced stage, HR-negative tumors.
An increased body mass index (BMI) may negatively affect disease progression in patients with T1G3 non-muscle-invasive bladder cancer, according to study data.
Women with ER-positive BC who stop therapy after 5 years have steady recurrence rate up to 20 years afterward.
A randomized study assessed the impact of ConquerFear, a novel intervention developed from various models of cognitive therapy, and Taking-it-Easy, an intervention based on models that promote relaxation, on cancer survivors’ ability to manage their fear of cancer recurrence.
In this study, the impact of cholesterol-lowering medications on breast cancer recurrence in women receiving adjuvant endocrine therapy was investigated.
The Attention and Interpretation Modification for Fear of Breast Cancer Recurrence (AIM-FBCR) intervention helped reduce health worries for survivors of breast cancer.
Findings at 6 and 12 months after treatment for advanced head and neck cancer indicate a higher risk of recurrences for those reporting cachexia after their treatment.
Delayed radiation therapy (RT) after surgery significantly increased the risk of recurrent disease in women treated for very early breast cancer.
Prolonged nightly fasting may reduce the risk of recurrence for patients with breast cancer.